IL17A and rheumatoid arthritis: Pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6, IL-8 and IL-17A, stimulate inflammatory responses in arthritic joints and synovial tissues; as such, these cytokines have been reported as potential therapeutic targets for RA [3,25,26,27,28].